Moderna Ceo News Today

Moderna COVID-19 vaccine might see 400% price increase. Moderna COVID-19 vaccine price might reportedly increase by roughly 400 percent, making it cost more than $100 per dose.

Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday.

American biotechnology firm Moderna will set up a manufacturing facility in Kenya, its first in Africa, to produce messenger RNA (mRNA) vaccines, including Covid-19 shots.

"The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.

Stock markets across the globe have plunged after Moderna CEO expressed his doubts regarding the efficacy of vaccines against the Omicron COVID-19 variant.

Omicron which the World Health Organization WHO said carries a very high risk of infection surges has triggered global alarm with border closures casting a shadow over a nascent economic recovery from a two year pandemic

Drugmaker Moderna set off fresh alarm bells in financial markets on Tuesday as the firm's chief warned that COVID-19 vaccines are unlikely to be as effective against the Omicron variant as they have been against the Delta version.

“There is no world, I think, where [the effectiveness] is the same level . . . we had with Delta,", the Financial Times quoted him as saying.

Moderna CEO Stephane Bancel said that existing COVID-19 vaccines are likely to be less effective against the Omicron variant of the coronavirus.

Moderna CEO Stephane Bancel said that existing COVID-19 vaccines are likely to be less effective against the Omicron variant of the coronavirus.